Although certain diets are sometimes touted as solutions for multiple sclerosis, they often lack evidence to support their claims, one expert says. 4 Common Myths About Multiple Sclerosis and Diet ...

UC Riverside study may lead to new treatments for multiple sclerosis. Multiple sclerosis (MS) affects an estimated 2.3 ...

TG Therapeutics, Inc.'s BRIUMVI saw Q1 2025 revenue surge 137% YoY. Click to learn about TGTX growth, upcoming trials, and ...

Compr Ophthalmol Update. 2007;8(1):39-49. Disclosure: Dr. Balcer has served as a consultant for development of visual outcomes for trials for Biogen Idec, Merck Serono, Sirtris Pharmaceuticals ...

Children most affected by MS-related biological aging appeared to be aging up to two years faster than kids without MS, even ...

Ocrelizumab is one of the DMTs approved in India, which can be used in all subtypes of multiple sclerosis and is the only treatment approved for the primary progressive form of MS. It works by ...

Understanding Multiple Sclerosis (MS): Learn about its early symptoms, challenges in diagnosis, and the importance of early intervention for effective management.

People with multiple sclerosis, an autoimmune disease that affects the central nervous system (CNS), are known to have imbalances in their gut microbiome — the collection of bacteria, fungi, and ...

Primary lateral sclerosis (PLS) is a neurodegenerative disorder of the adult motor system. Characterised by a slowly progressive upper motor neuron syndrome, the diagnosis is clinical, after exclusion ...

Lemtrada was approved by the U.S. Food and Drug Administration in November 2014 for the treatment of adults with relapsing forms of multiple sclerosis (MS), including relapsing-remitting MS and ...

Objective: To test the effectiveness and long term safety of cannabinoids in multiple sclerosis (MS), in a follow up to the main Cannabinoids in Multiple Sclerosis (CAMS) study. Methods: In total, 630 ...